4.7 Article

Risk Factors of Peritoneal Recurrence and Outcome of Resected Peritoneal Recurrence After Liver Resection in Hepatocellular Carcinoma: Review of 1222 Cases of Hepatectomy in a Tertiary Institution

期刊

ANNALS OF SURGICAL ONCOLOGY
卷 19, 期 7, 页码 2246-2255

出版社

SPRINGER
DOI: 10.1245/s10434-012-2260-3

关键词

-

向作者/读者索取更多资源

Reports on the risk factors of peritoneal recurrence (PR) after liver resection for hepatocellular carcinoma are lacking. We examined the risk factors of PR after hepatectomy and the outcome of resected PR at our institution. We retrospectively reviewed the data from 1,222 patients who underwent hepatectomies for hepatocellular carcinoma in Samsung Medical Center from January 2006 to August 2010. We identified patients with PR and studied the risk factors and outcomes of resected PR. The rate of PR was 3.0% (n = 36). The mean +/- A SD age of patients was 54.0 +/- A 10.2 years. Among those with PR, 23 patients (63.9%) had unresectable disease and 13 patients (36.1%) had resectable disease. Multivariate analysis found that tumor size > 50 mm, presence of microvascular invasion, bile duct invasion, and positive margins were significant risk factors of PR after liver resection. The median overall survival (OS) for resectable PR was 33.0 (28.0-61.6) months compared to 14.0 (6.8-21.2) months for unresectable PR (P = 0.009). Cox regression analysis demonstrated that resected PR [hazard ratio (HR) 0.042, P = 0.001] and interval between hepatectomy and PR (> 6months) (HR 0.195, P = 0.016) were positive prognostic factors for OS, while alfa-fetoprotein > 200 ng/dl at detection of PR (HR 11.321, P = 0.015) and serosal involvement of primary hepatocellular carcinoma (HR 25.616, P = 0.007) were negative prognostic factors for OS. We found that tumor size > 50 mm, presence of microvascular invasion, bile duct invasion, and positive resection margins were significant risk factors of PR after liver resection. Selected patients with resected PR had significantly better OS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Pretransplant mycophenolate mofetil may be associated with reduced intrahepatic cholangiopathy in ABO-incompatible liver transplantation

Jinsoo Rhu, Jong Man Kim, Gyu-seong Choi, Jae-Won Joh

Summary: This study analyzed the clinical impact of pretransplant administration of mycophenolate mofetil in reducing intrahepatic cholangiopathy in ABO-incompatible liver transplantation. The results showed that patients who underwent open surgery and received pretransplant mycophenolate mofetil had a lower incidence of intrahepatic cholangiopathy in ABO-incompatible liver transplantation. This suggests that pretransplant mycophenolate mofetil can reduce the risk of intrahepatic cholangiopathy.

LIVER TRANSPLANTATION (2023)

Article Gastroenterology & Hepatology

Quantitative Prediction of Posttransplant Hepatocellular Carcinoma Prognosis Using ADV Score: Validation with Korea-Nationwide Transplantation Registry Database

Gil-Chun Park, Shin Hwang, Young Kyoung You, YoungRok Choi, Jong Man Kim, Dong Jin Joo, Je Ho Ryu, Donglak Choi, Bong-Wan Kim, Dong-Sik Kim, Yang Won Nah, Koo Jeong Kang, Jai Young Cho, Hee Chul Yu, Deok Gie Kim

Summary: The aim of this study is to validate the prognostic impact of ADV score for predicting prognosis of HCC following liver transplantation. ADV score has been reported as a prognostic surrogate biomarker of HCC following LT and hepatectomy.

JOURNAL OF GASTROINTESTINAL SURGERY (2023)

Article Gastroenterology & Hepatology

Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea-Japan collaborative study with 9200 patients

Woo-Hyoung Kang, Shin Hwang, Masaki Kaibori, Jong Man Kim, Kyung Sik Kim, Tsuyoshi Kobayashi, Hiroto Kayashima, Yang Seok Koh, Keiichi Kubota, Akira Mori, Yutaka Takeda, Sung Su Yun, Kousuke Matsui, Kan Toriguchi, Hiroaki Nagano, Myung Hee Yoon, Yuji Soejima, Shunichi Ariizumi, Bum-Soo Kim, Yohan Park, Hee Chul Yu, Bong Wan Kim, Jung Bok Lee, Sang-Jae Park, Jin-Young Jang, Hiroki Yamaue, Masafumi Nakamura, Masakazu Yamamoto, Itaru Endo

Summary: The ADV score, calculated from the concentrations of AFP, DCP, and TV, has been shown to be prognostic of HCC recurrence following HR or liver transplantation. This international validation study demonstrated that ADV score is an integrated surrogate biomarker for post-resection prognosis of HCC.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2023)

Letter Gastroenterology & Hepatology

Reply: Can sexagenarian donors be feasibly indicated for living donor liver transplantation?

Jong Man Kim

LIVER TRANSPLANTATION (2023)

Article Gastroenterology & Hepatology

Improved recurrence-free survival in patients with HCC with post-transplant plasma exchange

Namkee Oh, Jinsoo Rhu, Jong Man Kim, Seungwook Han, Sung Jun Jo, Sunghyo An, Sunghae Park, Sang Oh Yoon, Manuel Lim, Jaehun Yang, Jieun Kwon, Gyu-Seong Choi, Jae-Won Joh

Summary: This study investigated the role of total plasma exchange (TPE) in cancer treatment. It found that TPE improved oncological outcomes in patients with hepatocellular carcinoma (HCC) who underwent ABO-incompatible living donor liver transplantation. Patients who received post-transplant TPE had better HCC-specific recurrence-free survival, especially in advanced cases with microvascular invasion and beyond Milan criteria.

LIVER TRANSPLANTATION (2023)

Article Gastroenterology & Hepatology

Benefit of living donor liver transplantation in graft survival for extremely high model for end-stage liver disease score ≥35

Sang Oh. Yun, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh

Summary: The study shows that LDLT is comparable to DDLT in terms of graft survival for high-MELD liver transplantation. Biliary complications are more common in LDLT group while viral infection, postoperative uncontrolled ascites, and postoperative hemodialysis are more common in DDLT group. Acute chronic liver failure, intraoperative RBC transfusion, and early postoperative complications are risk factors for graft failure in LDLT group.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2023)

Article Oncology

Long-Term Outcomes of Liver Transplantation in Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Comparison with Portal Vein Tumor Thrombus

Ji Soo Lee, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh

Summary: Liver transplantation in patients with hepatocellular carcinoma (HCC) with bile duct tumor thrombus (BDTT) remains controversial. This study analyzed the long-term recurrence and overall survival rates in HCC patients with BDTT after liver transplantation and compared them with the results in HCC patients with portal vein tumor thrombus (PVTT). The study found that HCC patients with BDTT had similar rates of recurrence and survival compared to HCC patients with PVTT after long-term follow-up after liver transplantation.

CANCERS (2023)

Article Nursing

Sleep Quality and Related Factors Among Liver Transplant Recipients in Korea: A Cross-Sectional Study

Serah Lim, Mona Choi, Heejung Kim, Jong Man Kim

Summary: This study assessed sleep quality in liver transplant recipients in Korea and found that poor sleep quality was associated with symptom experience, depression, and family support. The results can be used to develop nursing strategies to improve sleep quality in liver transplant recipients.

JOURNAL OF NURSING RESEARCH (2023)

Article Surgery

Hepatic venous territory mapping in living donor liver transplantation using right liver graft: an objective parameter for venous reconstruction

Jaehun Yang, Jinsoo Rhu, Jieun Kwon, Gyu-Seong Choi, Jong Man Kim, Woo Kyoung Jeong, Jae -Won Joh

Summary: This study evaluated the clinical significance of hepatic venous territory mapping in living donor liver transplantation. The results showed that reconstruction of the inferior and middle hepatic veins has a significant impact on clinical outcomes, and hepatic venous territory mapping can provide an objective measure for successful reconstruction of venous branches.

ANNALS OF SURGICAL TREATMENT AND RESEARCH (2023)

Article Medicine, General & Internal

Analysis of Antibody Responses After COVID-19 Vaccination in Liver Transplant Recipients: A Single-Center Study

Young Ju Oh, Jongman Kim, Eun-Suk Kang, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh

Summary: This study aimed to provide evidence of antibody responses after COVID-19 vaccination in liver transplant (LT) recipients. Among the 46 patients enrolled in the study, 87% demonstrated an antibody response after the second dose of the vaccine. The study also found that patients with lower levels of immunosuppressive drugs before and after vaccination had a significantly higher antibody response.

JOURNAL OF KOREAN MEDICAL SCIENCE (2023)

Article Surgery

Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations

Sang Oh Yun, Jong Man Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae -Won Joh

Summary: This study evaluated the prognostic value of non-invasive biomarkers after curative liver resection for hepatocellular carcinoma (HCC). The results showed that FIB-4 was a significant predictor of HCC prognosis after curative liver resection, while APRI had less value in prognosis. The hazard ratios for 2-year recurrence-free survival and overall survival were 1.81 and 2.36, respectively, for FIB-4. This study suggests that FIB-4 is an important predictor of HCC prognosis after curative liver resection.

ANNALS OF SURGICAL TREATMENT AND RESEARCH (2023)

Article Surgery

Upper thigh skeletal muscle index predicts outcomes in liver transplant recipients

Manuel Lim, Jong Man Kim, Jaehun Yang, Jieun Kwon, Kyeong Deok Kim, Eun Sung Jeong, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh, Suk-Koo Lee

Summary: This study determined the optimal cut-off value for UT-SMI and found that sarcopenia diagnosed by UT-SMI is associated with outcomes in LT recipients.

ANNALS OF SURGICAL TREATMENT AND RESEARCH (2023)

Article Surgery

Ventilator support in the pretransplant period predisposes early graft failure after deceased donor liver transplantation

Nuri Lee, Sora Cha, Jongman Kim, Yunmi Lee, Enjin Kang, Hyun Jung Kim, Seung Hui Hong, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh

Summary: This study aims to identify the risk factors for early 30-day graft failure after deceased donor liver transplantation (DDLT), and shows that pretransplant ventilatory support is a major predisposing factor for graft failure after DDLT.

ANNALS OF SURGICAL TREATMENT AND RESEARCH (2023)

Article Medicine, General & Internal

Cancer Incidence in Living Liver Donors After Donor Hepatectomy

Jongman Kim, Jae Heon Kim, Hyun Jung Kim

Summary: This study found that living liver donors have a significantly higher incidence of liver and thyroid cancer compared to a matched healthy control group. The findings suggest the need for medical surveillance, especially for liver cancer, among living liver donors.

JOURNAL OF KOREAN MEDICAL SCIENCE (2023)

暂无数据